Given that we observed a fair diagnostic accuracy of CSF NfL for identifying cases preclinical AD, NfL can form a highly accurate diagnostic classifier in conjunction with biomarkers associated other pathological changes. The gene discussed is NEFL; the disease is Alzheimer disease.